Literature DB >> 28504925

Comparative diagnostic test evaluation of serum procalcitonin and C-reactive protein in suspected bloodstream infections in children with cancer.

Swapna R Nath1, Sabeena Jayapalan2, Harikumaran Nair2, P Kusumakumary3, N S Prema2, T Priyakumari3, K Rajamohanan2.   

Abstract

PURPOSE: To compute diagnostic test properties of C-reactive protein (CRP) and serum procalcitonin (PCT) levels in bloodstream infections in children with cancer and suspected sepsis, in comparison with blood culture as the gold standard.
METHODOLOGY: Consecutive paediatric cancer patients, aged ≤14 years, with clinically suspected bloodstream infections were evaluated with blood culture and assay of PCT and CRP levels. Blood culture was taken as the gold standard for comparison. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), likelihood ratio (LR) and receiver operating characteristic (ROC) with area under ROC curve (AUC) were calculated to assess the diagnostic test performance for PCT and CRP.Results/Key findings. The ROC curve for PCT was better than that for CRP, with an AUC of 0.751 for PCT at a cut-off of 2.25 ng ml-1. The AUC for CRP was 0.638 at a cut-off of 8.0 mg dl-1. Among the three cut-off values of PCT selected from the ROC curve applicable to the patients under study, the cut-off value of ≥0.49 ng ml-1 had the maximum sensitivity of 81.4 % and an NPV of 94.67 %; ≥2.25 ng ml-1 had a sensitivity and specificity of 65.12 and 71.6 %, respectively, and ≥6.47 ng ml-1 had a maximum specificity of 82.10 %. For CRP, the cut-off value of ≥5.3 mg dl-1 had the maximum sensitivity of 72.09 %; ≥8.0 mg dl-1 had a sensitivity and specificity of 58.14 and 68.09 %, respectively, and ≥8.4 mg dl-1 had the maximum specificity of 70.04 %.
CONCLUSION: PCT is a better serological marker for excluding bloodstream infections than CRP. The cut-off value of 0.49 ng ml-1 with a negative predictive value of 94.67 % will be ideal in a clinical setting of immune-compromised children with suspected sepsis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28504925     DOI: 10.1099/jmm.0.000478

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients.

Authors:  Zhifang Zhao; Xuze Li; Yunxia Zhao; Dongchang Wang; Yahua Li; Le Liu; Tao Sun; Gang Chen
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

2.  Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study.

Authors:  Thomas Waterfield; Julie-Ann Maney; Martin Hanna; Derek Fairley; Michael D Shields
Journal:  BMC Pediatr       Date:  2018-12-12       Impact factor: 2.125

Review 3.  Is Procalcitonin Useful in Pediatric Critical Care Patients?

Authors:  Sara Bobillo-Perez; Javier Rodríguez-Fanjul; Iolanda Jordan Garcia
Journal:  Biomark Insights       Date:  2018-08-07

4.  Diagnostic value of procalcitonin, C-reactive protein and lactate dehydrogenase in paediatric malignant solid tumour concurrent with infection and tumour progression.

Authors:  Fan Li; Weiling Zhang; Huimin Hu; Yi Zhang; Dongsheng Huang
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

5.  Diagnostic Accuracy of Immunologic Biomarkers for Accurate Diagnosis of Bloodstream Infection in Patients with Malignancy: Procalcitonin in Comparison with C-Reactive Protein.

Authors:  Mansoureh Shokripour; Navid Omidifar; Kourosh Salami; Mohsen Moghadami; Babak Samizadeh
Journal:  Can J Infect Dis Med Microbiol       Date:  2020-10-31       Impact factor: 2.471

6.  Diagnostic Value of Thromboelastography (TEG) for the Diagnosis of Death in Infected Patients.

Authors:  Jingchao Xuan; Junyu Wang; Bing Wei
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

Authors:  Fabian J S van der Velden; Andrew R Gennery; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.